aha_2025
Différences
Ci-dessous, les différences entre deux révisions de la page.
| Prochaine révision | Révision précédente | ||
| aha_2025 [2025/10/30 21:30] – créée clementbecle | aha_2025 [2025/11/09 19:39] (Version actuelle) – clementbecle | ||
|---|---|---|---|
| Ligne 1: | Ligne 1: | ||
| - | ====== AHA/ACC 2025 ====== | + | ====== AHA 2025 ====== |
| + | * [[lb.01|LBS.01 Groundbreaking Trials in Cardiometabolic Therapeutics]] : DR10624, CTX310, Olezarsen, Vesalius-CV | ||
| + | * [[LBS.02|LBS.02 Dilemmas in antithrombotic therapy in AF care post procedures]] : Adapt-AF, Optima-AF, Closure-AF et Ocean trial. | ||
| + | * [[LBS.03|LBS.03 Cutting Edge Valve and Coronary Trials]] : Recovery, Ablation trial, Favor-IV QVAS et Top trial. | ||
| + | * [[LBS.04|LBS.04 Cardiometabolic and Lifestyle Interventions for AF]] : Dare-AF, Meta-AF et DECAF. | ||
| + | * [[LBS.05|LBS.05 Practice Changing Trials in Blood Pressure Control ]] | ||
| + | * [[LBS.06|LBS.06 Approaches to Ischemic Heart Disease Before During and After Hospitalization]] | ||
| + | * [[LBS.07|LBS.07 Recipes for Success in Heart Failure]] : Poly-HF, Caviar, Food-HF, Surpass-CVOT | ||
aha_2025.1761856239.txt.gz · Dernière modification : de clementbecle
